Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 14 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 11185581

    Human rotavirus G9P[6] strain and use as a vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  2. US 11180751

    CRISPR enzymes and systems

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

  3. US 11174292

    Substitutions-modified prefusion RSV F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted

  4. US 11173201

    Methods and compositions for inducing protective immunity against filovirus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted

  5. US 11167025

    Altering the immundominance hierarchy using a DNA vaccine expressing conserved regions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  6. US 11167012

    Peptide inhibition of CCR3-mediated diseases or conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  7. US 11154574

    Tumor infiltrating lymphocytes and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  8. US 11147837

    Modified cells and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted

  9. US 11147867

    Stabilized influenza hemagglutinin stem region trimers and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted

  10. US 11149082

    Multispecific antibodies targeting human immunodeficiency virus and methods of using the same

    The United States of America, As Represented By · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted

  11. US 11136356

    Recombinant HIV-1 envelope proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  12. US 11129835

    Methods and compositions for the inhibition of PIN1

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  13. US 11130785

    Prefusion RSV F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  14. US 11116830

    Bacterial polysaccharide-conjugated carrier proteins and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted

  15. US 11111306

    IL-7R-alpha specific antibodies for treating acute lymphoblastic leukemia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  16. US 11110089

    Pyridazinones and their use in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  17. US 11110150

    Complexes of IL-15 and IL-15Ralpha and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  18. US 11110181

    Virus-like particle conjugates for diagnosis and treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  19. US 11111478

    Methods of producing T memory stem cell populations

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  20. US 11103572

    Thermal inactivation of rotavirus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted

  21. US 11098054

    Englerin derivatives for treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Sciences · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted

  22. US 11098283

    T cells modified to overexpress c-Myb

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted

  23. US 11098053

    Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted

  24. US 11096927

    Anti-flavivirus compounds and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.